Biomimetic Recognition of SARS‐CoV‐2 Receptor‐Binding Domain N‐Glycans by an Antiviral Synthetic Receptor

Recognition of glycans by simple synthetic receptors is a key issue in supramolecular chemistry, endowed with relevant implications in glycobiology and medicine. In this context, glycoproteins featuring N-glycans represent an important biological target, because they are often exploited by enveloped viruses in adhesion and infection processes. However, a direct evidence for their recognition by a synthetic receptor targeting N-glycans is still missing in the literature. Using a combination of glycoengineering and mass spectrometry techniques, we present here the direct evidence of biomimetic recognition of complex-type N-glycans exposed on the receptor-binding domain (RBD) of the wild-type spike protein of SARS-CoV-2 by a biologically active, synthetic receptor.

Authors

Institutions

Publication Details

Journal
ChemBioChem
Published
2025-02-21
DOI
https://doi.org/10.1002/cbic.202500106
Citations
1
Primary Topic
Glycosylation and Glycoproteins Research
Type
article
Field-Weighted Citation Impact
0.81

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Biomimetic Recognition of SARS‐CoV‐2 Receptor‐Binding Domain N‐Glycans by an Antiviral Synthetic Receptor

Rita Grandori, Renata Grifantini, Raffaele De Francesco, Stefano Roelens et al.
1 citations
ChemBioChem
Glycosylation and Glycoproteins Research
0.81
article

Biomimetic Recognition of SARS‐CoV‐2 Receptor‐Binding Domain N‐Glycans by an Antiviral Synthetic Receptor

Rita Grandori, Renata Grifantini, Raffaele De Francesco, Stefano Roelens, Lorena Donnici, Cristina Nativi, Oscar Francesconi, Mirco Toccafondi, Francesco Milanesi, Marco Fragai, Carlo Santambrogio, Erika Ponzini, Elisa Pesce
article en
1 citations

Abstract

Recognition of glycans by simple synthetic receptors is a key issue in supramolecular chemistry, endowed with relevant implications in glycobiology and medicine. In this context, glycoproteins featuring N-glycans represent an important biological target, because they are often exploited by enveloped viruses in adhesion and infection processes. However, a direct evidence for their recognition by a synthetic receptor targeting N-glycans is still missing in the literature. Using a combination of glycoengineering and mass spectrometry techniques, we present here the direct evidence of biomimetic recognition of complex-type N-glycans exposed on the receptor-binding domain (RBD) of the wild-type spike protein of SARS-CoV-2 by a biologically active, synthetic receptor.

ChemBioChemVol. 26(7)
Forschungszentrum Jülich (DE), University of Milan (IT), National Interuniversity Consortium of Materials Science and Technology (IT), Istituto Nazionale Genetica Molecolare (IT), University of Florence (IT), University of Milano-Bicocca (IT)
Università degli Studi di Milano, Dipartimenti di Eccellenza, Università degli Studi di Firenze, Ministero dell'Università e della Ricerca
Openalex Percentile: Top 31%
Glycosylation and Glycoproteins Research
0.81
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.